Criteria for judging the immune markers of COVID‐19 disease vaccines

As severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) sweeping the world, effective and affordable vaccines are in urgent need. A reliable system for the assessment of SARS‐CoV‐2 vaccines would boost the development of vaccines and reduce the research cost. We constructed a logistic regres...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Nan, Fu, Haoxuan, Pu, Dan, Quan, Yuxin, Li, Yueyi, Yin, Xiaomeng, Wei, Yuhao, Wang, Hang, Ma, Xuelei, Wei, Xiawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719528/
https://www.ncbi.nlm.nih.gov/pubmed/35005708
http://dx.doi.org/10.1002/mco2.109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719528/
https://www.ncbi.nlm.nih.gov/pubmed/35005708
http://dx.doi.org/10.1002/mco2.109

Ejemplares similares